nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Valganciclovir—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Valganciclovir—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Valganciclovir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00137	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Valganciclovir—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Valganciclovir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Valganciclovir—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Valganciclovir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Valganciclovir—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Valganciclovir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Valganciclovir—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Valganciclovir—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Valganciclovir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Valganciclovir—Infection—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00134	CcSEcCtD
Valganciclovir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Valganciclovir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Valganciclovir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Valganciclovir—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Infection—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00131	CcSEcCtD
Valganciclovir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Valganciclovir—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Valganciclovir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Valganciclovir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Valganciclovir—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Valganciclovir—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Valganciclovir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Valganciclovir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Valganciclovir—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Valganciclovir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Valganciclovir—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Valganciclovir—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Valganciclovir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00126	CcSEcCtD
Valganciclovir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Valganciclovir—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Valganciclovir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Valganciclovir—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00125	CcSEcCtD
Valganciclovir—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Valganciclovir—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Valganciclovir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Valganciclovir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Valganciclovir—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Valganciclovir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Valganciclovir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00122	CcSEcCtD
Valganciclovir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Valganciclovir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00121	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Valganciclovir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Valganciclovir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Valganciclovir—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Valganciclovir—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0012	CcSEcCtD
Valganciclovir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Valganciclovir—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Valganciclovir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Valganciclovir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Valganciclovir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Valganciclovir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Valganciclovir—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Valganciclovir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Valganciclovir—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Valganciclovir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Valganciclovir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00114	CcSEcCtD
Valganciclovir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Valganciclovir—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Valganciclovir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Valganciclovir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Valganciclovir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00112	CcSEcCtD
Valganciclovir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Valganciclovir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Valganciclovir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Valganciclovir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Valganciclovir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Valganciclovir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Valganciclovir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.0011	CcSEcCtD
Valganciclovir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Valganciclovir—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Valganciclovir—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Valganciclovir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Valganciclovir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Valganciclovir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Valganciclovir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Valganciclovir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Valganciclovir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Valganciclovir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00106	CcSEcCtD
Valganciclovir—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00105	CcSEcCtD
Valganciclovir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Valganciclovir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00104	CcSEcCtD
Valganciclovir—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Valganciclovir—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Valganciclovir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Valganciclovir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Valganciclovir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00101	CcSEcCtD
Valganciclovir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000992	0.000992	CcSEcCtD
Valganciclovir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000992	0.000992	CcSEcCtD
Valganciclovir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.000991	CcSEcCtD
Valganciclovir—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000989	0.000989	CcSEcCtD
Valganciclovir—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000989	0.000989	CcSEcCtD
Valganciclovir—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000982	0.000982	CcSEcCtD
Valganciclovir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000972	0.000972	CcSEcCtD
Valganciclovir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000966	0.000966	CcSEcCtD
Valganciclovir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.000966	CcSEcCtD
Valganciclovir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000953	0.000953	CcSEcCtD
Valganciclovir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000953	0.000953	CcSEcCtD
Valganciclovir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000947	0.000947	CcSEcCtD
Valganciclovir—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000938	0.000938	CcSEcCtD
Valganciclovir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.000937	CcSEcCtD
Valganciclovir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000933	0.000933	CcSEcCtD
Valganciclovir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.000922	CcSEcCtD
Valganciclovir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000922	0.000922	CcSEcCtD
Valganciclovir—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000917	0.000917	CcSEcCtD
Valganciclovir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000914	0.000914	CcSEcCtD
Valganciclovir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000912	0.000912	CcSEcCtD
Valganciclovir—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000908	0.000908	CcSEcCtD
Valganciclovir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000903	0.000903	CcSEcCtD
Valganciclovir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.0009	CcSEcCtD
Valganciclovir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000891	0.000891	CcSEcCtD
Valganciclovir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000891	0.000891	CcSEcCtD
Valganciclovir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000872	0.000872	CcSEcCtD
Valganciclovir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000872	0.000872	CcSEcCtD
Valganciclovir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00087	0.00087	CcSEcCtD
Valganciclovir—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000858	0.000858	CcSEcCtD
Valganciclovir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000856	0.000856	CcSEcCtD
Valganciclovir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000856	0.000856	CcSEcCtD
Valganciclovir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000848	0.000848	CcSEcCtD
Valganciclovir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000848	0.000848	CcSEcCtD
Valganciclovir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000844	0.000844	CcSEcCtD
Valganciclovir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000844	0.000844	CcSEcCtD
Valganciclovir—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000843	0.000843	CcSEcCtD
Valganciclovir—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000842	0.000842	CcSEcCtD
Valganciclovir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.000841	CcSEcCtD
Valganciclovir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000841	0.000841	CcSEcCtD
Valganciclovir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000839	0.000839	CcSEcCtD
Valganciclovir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000831	0.000831	CcSEcCtD
Valganciclovir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000829	0.000829	CcSEcCtD
Valganciclovir—Depression—Prednisone—chronic obstructive pulmonary disease	0.000829	0.000829	CcSEcCtD
Valganciclovir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000826	0.000826	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000815	0.000815	CcSEcCtD
Valganciclovir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.000809	CcSEcCtD
Valganciclovir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.000806	CcSEcCtD
Valganciclovir—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000803	0.000803	CcSEcCtD
Valganciclovir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.000801	CcSEcCtD
Valganciclovir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.0008	CcSEcCtD
Valganciclovir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0008	0.0008	CcSEcCtD
Valganciclovir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000797	0.000797	CcSEcCtD
Valganciclovir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000784	0.000784	CcSEcCtD
Valganciclovir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000774	0.000774	CcSEcCtD
Valganciclovir—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000772	0.000772	CcSEcCtD
Valganciclovir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.000755	CcSEcCtD
Valganciclovir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.000752	CcSEcCtD
Valganciclovir—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00075	0.00075	CcSEcCtD
Valganciclovir—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000746	0.000746	CcSEcCtD
Valganciclovir—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000742	0.000742	CcSEcCtD
Valganciclovir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000733	0.000733	CcSEcCtD
Valganciclovir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000729	0.000729	CcSEcCtD
Valganciclovir—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000729	0.000729	CcSEcCtD
Valganciclovir—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000712	0.000712	CcSEcCtD
Valganciclovir—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000705	0.000705	CcSEcCtD
Valganciclovir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000697	CcSEcCtD
Valganciclovir—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000677	0.000677	CcSEcCtD
Valganciclovir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000674	0.000674	CcSEcCtD
Valganciclovir—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000667	CcSEcCtD
Valganciclovir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00066	0.00066	CcSEcCtD
Valganciclovir—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000659	0.000659	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000655	0.000655	CcSEcCtD
Valganciclovir—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000654	0.000654	CcSEcCtD
Valganciclovir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000649	0.000649	CcSEcCtD
Valganciclovir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000624	0.000624	CcSEcCtD
Valganciclovir—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000612	CcSEcCtD
Valganciclovir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000603	0.000603	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000601	0.000601	CcSEcCtD
Valganciclovir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.0006	0.0006	CcSEcCtD
Valganciclovir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000597	0.000597	CcSEcCtD
Valganciclovir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000586	0.000586	CcSEcCtD
Valganciclovir—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000584	0.000584	CcSEcCtD
Valganciclovir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.000579	CcSEcCtD
Valganciclovir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000563	0.000563	CcSEcCtD
Valganciclovir—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000561	0.000561	CcSEcCtD
Valganciclovir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000553	0.000553	CcSEcCtD
Valganciclovir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000551	0.000551	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000549	0.000549	CcSEcCtD
Valganciclovir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000546	0.000546	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000537	0.000537	CcSEcCtD
Valganciclovir—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00053	CcSEcCtD
Valganciclovir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00053	CcSEcCtD
Valganciclovir—Infection—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000527	CcSEcCtD
Valganciclovir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00052	CcSEcCtD
Valganciclovir—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000517	0.000517	CcSEcCtD
Valganciclovir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000515	CcSEcCtD
Valganciclovir—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000512	CcSEcCtD
Valganciclovir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000505	0.000505	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000483	CcSEcCtD
Valganciclovir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.000482	CcSEcCtD
Valganciclovir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000479	0.000479	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000476	0.000476	CcSEcCtD
Valganciclovir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000467	0.000467	CcSEcCtD
Valganciclovir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000461	CcSEcCtD
Valganciclovir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00046	0.00046	CcSEcCtD
Valganciclovir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000457	CcSEcCtD
Valganciclovir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000457	0.000457	CcSEcCtD
Valganciclovir—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000453	0.000453	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000437	0.000437	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000433	0.000433	CcSEcCtD
Valganciclovir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.000433	CcSEcCtD
Valganciclovir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000421	CcSEcCtD
Valganciclovir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000419	CcSEcCtD
Valganciclovir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000419	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000391	0.000391	CcSEcCtD
Valganciclovir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00038	0.00038	CcSEcCtD
Valganciclovir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000375	0.000375	CcSEcCtD
Valganciclovir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000363	CcSEcCtD
Valganciclovir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000351	CcSEcCtD
Valganciclovir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000337	CcSEcCtD
Valganciclovir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000334	CcSEcCtD
Valganciclovir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000332	CcSEcCtD
Valganciclovir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000315	CcSEcCtD
